(Q54263000)

27 May 2018

title

Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice. (English)

1 reference

27 May 2018

author name string

Guo-Qiang Sun

1

1 reference

27 May 2018

Yu-Bo Li

2

1 reference

27 May 2018

Bing Du

3

1 reference

27 May 2018

Yan Meng

4

1 reference

27 May 2018

publication date

26 June 2015

1 reference

27 May 2018

Clinical and Experimental Hypertension

published in

1 reference

27 May 2018

volume

37

1 reference

27 May 2018

issue

8

1 reference

27 May 2018

page(s)

616-621

1 reference

27 May 2018

Mixed messages on blood pressure goals

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Inhibition of the AMP-activated protein kinase-α2 accentuates agonist-induced vascular smooth muscle contraction and high blood pressure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol as an anticancer nutrient: molecular basis, open questions and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Aberrant endoplasmic reticulum stress in vascular smooth muscle increases vascular contractility and blood pressure in mice deficient of AMP-activated protein kinase-α2 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Maintenance of red blood cell integrity by AMP-activated protein kinase alpha1 catalytic subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

RhoA/Rho kinase (ROCK) alters fetuin-A uptake and regulates calcification in bovine vascular smooth muscle cells (BVSMC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Perspectives for production and application of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol supplementation reduces aortic atherosclerosis and calcification and attenuates loss of aerobic capacity in a mouse model of uremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Serotonin-induced ion channel modulations in mesenteric artery myocytes from normotensive and DOCA-salt hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Resveratrol in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641963.2015.1036060

10.3109/10641963.2015.1036060

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

26114354

1 reference

27 May 2018